Florida Hospital Tampa and Dr. James E. Lefler are the first in the Tampa Bay area to adopt the new FDA approved device called the Trevo Pro Clot Retriever manufactured by Stryker. The Trevo Pro is the next generation in clot removal technology. This powerful new tool literally "retrieves" blood clots from within the brain's vasculature restoring blood flow to the brain faster for patients suffering from acute ischemic stroke, where blood flow is blocked. This new device has the ability to significantly improve patient outcomes.
“Trevo Pro is used to perform what is called a mechanical thrombectomy, also known as clot removal”
"Trevo Pro is used to perform what is called a mechanical thrombectomy, also known as clot removal," said James E. Lefler, MD, co-director of the stroke program and neurointerventional radiologist at Florida Hospital Tampa. "The Trevo Pro entraps the clot in a way that can immediately allow blood to start flowing back to the brain. This new device is 92% effective, advancing our ability and leading patients to better outcomes. We now have four different devices to treat stroke patients, depending on the type and location of stroke. The Trevo Pro becomes a fourth option; our other devices include the Concentric Merci Retrieval System, The Penumbra System and Solitaire Stroke Device. "
The FDA approval is based on the TREVO 2 clinical trial, designed to assess the safety and efficacy of Trevo Pro Retrieval system for removing clots from ischemic stroke patients. The results also showed improvement in the National Institutes of Health Stroke Scale (NIHSS) score and shorter hospital stays.
Study shows community health workers can improve asthma care for children